Health-related quality of life and its determinants among patients with psoriasis at a referral hospital in Northwest Ethiopia

被引:4
作者
Belachew, Eyayaw Ashete [1 ]
Chanie, Gashaw Sisay [1 ]
Gizachew, Eshetie [2 ]
Sendekie, Ashenafi Kibret [1 ]
机构
[1] Univ Gondar, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia
[2] Univ Gondar, Coll Informat, Dept Informat Syst, Gondar, Ethiopia
关键词
psoriasis; health-related quality of life; determinants; Dermatology Life Quality Index; Ethiopia; LONG-TERM MANAGEMENT; PREVALENCE;
D O I
10.3389/fmed.2023.1183685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesThis study assessed health-related quality of life (HRQoL) and its determinants among patients with psoriasis having follow-ups at the University of Gondar Comprehensive Specialized Hospital (UoGCSH). Design, setting, and participantsA cross-sectional institutional-based study was conducted at the dermatologic clinic of UoGCSH from June to August 2022. Four hundred eligible patients with psoriasis were included in the study using a systematic random sampling technique. The main outcome measuredThe Dermatology Life Quality Index (DLQI) measurement scale was used to assess HRQoL. The relationship between HRQoL and independent predictor variables was investigated using bivariable and multivariate logistic regression analyses. Statistical significance was defined as a p-value of ResultsOf the 422 study subjects approached, 400 respondents with psoriasis were included in the final analysis. The mean (& PLUSMN;SD) age was 39.8 (& PLUSMN;17.2) years, and 56% were women. The most commonly prescribed medications were topical corticosteroids (68.3 %). The mean (& PLUSMN;SD) DLQI was 13.05 (7.82). More than three-fourths (78.5%) of the patients' HRQOL was affected, and its severity ranged from very large to extremely large. Being male (adjusted odd ratio) (AOR) = 0.373, 95% CI (0.171, 0.773), the use of alternative therapy (AOR) = 0.237, 95% CI (0.114, 0.494), duration of diseases (AOR) = 0.184, 95% CI (0.061, 0.557), duration on medication (AOR) =3.75, 95% CI (1.32, 10.73), presence of comorbidity (AOR) = 6.199, 95% CI (1.921, 20.00), and income were found to have a significant association with poor HRQoL. ConclusionPsoriasis patients had reduced HRQoL, which was lower than that of the normal population. The study identified that several variables contributed to this reduced HRQoL. Predictors that take into account interventions were essential for preserving patients' HRQoL.
引用
收藏
页数:10
相关论文
共 38 条
[1]   Management of Psoriasis in Africa and the Middle East: a Review of Current Opinion, Practice and Opportunities for Improvement [J].
Abdulghani, M. ;
Al Sheik, A. ;
Alkhawaiah, M. ;
Ammoury, A. ;
Behrens, F. ;
Benchikhi, H. ;
Benkaidali, I. ;
Doss, N. ;
El Gendy, A. ;
Mokhtar, I. ;
Odendaal, D. ;
Raboobee, N. ;
Thaci, D. ;
Weiss, R. ;
Whitaker, D. .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) :1573-1588
[2]   TUR-PSO: A cross-sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey [J].
Atakan, Nilgun ;
Yazici, Ayca Cordan ;
Ozarmagan, Guzin ;
Inaloz, Huseyin Serhat ;
Gurer, Mehmet Ali ;
Sabuncu, Ilham ;
Kiremitci, Ummuhan ;
Alper, Sibel ;
Aytekin, Sema ;
Arican, Ozer ;
Polat, Mualla ;
Dogan, Sibel ;
Aldinc, Emre .
JOURNAL OF DERMATOLOGY, 2016, 43 (03) :298-304
[3]  
Augustin M., 2016, HDB PSORIASIS PSORIA, P101
[4]   Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany [J].
Augustin, Matthias ;
Reich, Kristian ;
Glaeske, Gerd ;
Schaefer, Ines ;
Radtke, Marc .
ACTA DERMATO-VENEREOLOGICA, 2010, 90 (02) :147-151
[5]  
Aynalem SW., 2014, SCI J CLIN MED, V3, P106, DOI [10.11648/j.sjcm.20140306.12, DOI 10.11648/J.SJCM.20140306.12]
[6]  
Barot P. A., 2015, National Journal of Medical Research, V5, P93
[7]   Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature [J].
Belinchon, I. ;
Rivera, R. ;
Blanch, C. ;
Comellas, M. ;
Lizan, L. .
PATIENT PREFERENCE AND ADHERENCE, 2016, 10 :2357-2367
[8]   Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis [J].
Blome, Christine ;
Simianer, Stefan ;
Purwins, Sandra ;
Laass, Anna ;
Rustenbach, Stephan Jeff ;
Schaefer, Ines ;
Radtke, Marc ;
Augustin, Matthias .
DERMATOLOGY, 2010, 221 (02) :154-159
[9]   Etiology and Pathogenesis of Psoriasis [J].
Boehncke, Wolf-Henning .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (04) :665-+
[10]  
Chen C-Y., 2016, ARCH DERMATOL RES, V310, P443